focus -WSS

focus

author：fashion 2025-09-27 09:55:06 - browse：431

Sanofi CEO Paul Hudson Courtesy Sanofi

NEW YORK — The top executives at French drug giant Sanofi on Wednesday defended their decision to reduce earnings forecasts for 2024 in order to fund more research studies of new medicines they say could one day generate billions of dollars in annual sales.

CEO Paul Hudson and Houman Ashrafian, Sanofi’s new head of R&D, made their remarks in an exclusive interview with STAT ahead of a full-day meeting with analysts here. When the cuts to earnings were first announced Oct. 27, along with a plan to spin off the company’s consumer products division, shares dove 18% and have yet to fully recover. The share price is down 5% since the beginning of 2023.

“I’ve been waiting four years for a situation where we could put [out] the pipeline, as impressive as it is, and declare that we’re going to be the world’s leading immunology company,” said Hudson, who took over as CEO in 2019. “So it’s quite an important moment for us. And it’s an important moment to declare that we’re back in science, because I could argue that we haven’t been where we needed to be.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Class action alleges UnitedHealth concealed DOJ probe

WSS

The effects of a landmark ruling on DNA ownership are becoming clearer

For BCIs, commercial hurdles may be bigger than scientific ones

'Ancient DNA,' 23andMe reveal African American ancestries

ProMED, early warning system on disease outbreaks, in peril

White House drug shortage group privately met with industry

As health system earnings go up, health insurance stocks go down

knowledge

focus

leisure time

Tori Bowie and the unacceptable rates of Black maternal death

2 US Navy sailors arrested for allegedly spying for China

What does generative AI mean for health care? We asked experts

Brain technologies pose threats that are all too real, experts warn

After affirmative action ruling, medical educators look to 'holistic review'

How a small hospital in rural Puerto Rico survived Hurricane Maria

23andMe had bad news about my health. I wish a person had delivered it

Deliver public health messages at the right time

In Memoriam: Notable people who died in 2023

My superpower is killing ticks

hotspot

As health system earnings go up, health insurance stocks go down

Can gargling with Listerine treat gonorrhea of the mouth?

BIO to announce reorganization, senior leaders expected to depart

The drug industry sees a key ally in the Senate prevail

PBM executives asked to testify by House panel

Can gargling with Listerine treat gonorrhea of the mouth?

explore

hotspot

leisure time

entertainment